Effect of microencapsulated biopeptide on its stability in gastrointestinal tract model in in-vitro studies
Volume 19 • Issue 2
Tikhonov Sergey L., Tikhonova Natalya V.
DOI: https://doi.org/10.22450/1999-6837-2025-19-2-155-161
Published on: 20.05.2025
Bioactive peptides are short sequences of amino acids with a wide range of physiological activities, including antihypertensive, antioxidant, and antidiabetic properties. However, their clinical and nutritional use is limited by their low resistance in the body, especially in the gastrointestinal tract, where enzymes rapidly destroy peptides, reducing their biological activity. In this study, a method of microencapsulation of bioactive peptides SP-20 (SQKKKNCPNGTRIRVPGPGP) in a fluidized bed is considered to increase its stability in the gastrointestinal tract model. The stability of the free and microencapsulated peptide was determined at successive stages of digestion: oral cavity, stomach, intestines. In vitro studies have shown that the microencapsulated peptide remains active in the intestine by 36% after 4 hours of digestion, and its release occurs within 9 hours, which is 1,8 times higher than the free peptide. The results obtained confirm the effectiveness of microencapsulation for the protection of bioactive peptides, ensuring their targeted delivery and prolonged release. It opens prospects for the development of functional food products and new therapeutic solutions.
Tikhonov S. L., Tikhonova N. V. Effect of microencapsulated biopeptide on its stability in gastrointestinal tract model in in-vitro studies. Dal'nevostochnyi agrarnyi vestnik. 2025;19;2:155–161. (in Russ.). https://doi.org/10.22450/1999-6837-2025-19-2-155-161.
Metrics
8
Views
2
Downloads